Hugues de Thé Selected Research

Hugues de Thé Research Topics

Disease

36	Neoplasms (Cancer) 12/2023 - 09/2002
33	Acute Promyelocytic Leukemia 03/2024 - 06/2003
30	Leukemia 03/2024 - 01/2004
12	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2020 - 06/2003
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 10/2005
7	Breast Neoplasms (Breast Cancer) 08/2013 - 03/2007
5	Infections 01/2022 - 06/2003
3	T-Cell Leukemia (Leukemia, T Cell) 06/2007 - 05/2006
3	T-Cell Lymphoma (Lymphoma, T Cell) 06/2007 - 11/2004
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 06/2011
2	Lymphoma (Lymphomas) 01/2020 - 06/2009
2	Genetic Translocation (Chromosomal Translocation) 11/2014 - 07/2012
2	Carcinoma (Carcinomatosis) 08/2013 - 01/2009
1	Congenital Heart Defects (Congenital Heart Defect) 11/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Listeriosis (Listeria Infection) 10/2017
1	Triple Negative Breast Neoplasms 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Skin Neoplasms (Skin Cancer) 09/2013
1	Opportunistic Infections (Opportunistic Infection) 08/2013
1	Acute Disease 07/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2011
1	Carcinogenesis 10/2010
1	Sarcoma (Soft Tissue Sarcoma) 10/2010
1	Pathologic Complete Response 01/2010
1	Squamous Cell Carcinoma of Head and Neck 02/2009
1	Bronchiolitis Obliterans Syndrome 02/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2009
1	Inflammation (Inflammations) 02/2009
1	Nijmegen Breakage Syndrome 06/2008
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2007

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2003
16	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2024 - 06/2003
13	ArsenicIBA 03/2024 - 01/2004
12	Arsenic Trioxide (Trisenox)FDA Link 01/2021 - 09/2002
10	Oncogene Proteins (Oncogene Protein)IBA 03/2024 - 05/2006
8	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 03/2024 - 06/2011
5	RetinoidsIBA 01/2021 - 10/2005
4	Estrogen ReceptorsIBA 01/2015 - 01/2010
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2014 - 07/2011
4	Interferon-alpha (Interferon Alfa)IBA 08/2013 - 01/2004
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2013 - 03/2007
3	InterferonsIBA 01/2021 - 01/2014
3	Histone Deacetylase InhibitorsIBA 01/2018 - 04/2014
3	CytokinesIBA 01/2018 - 08/2013
3	Retinoic Acid Receptor alphaIBA 11/2014 - 10/2005
3	Zidovudine (Retrovir)FDA LinkGeneric 08/2013 - 07/2006
3	Phenobarbital (Luminal)FDA Link 08/2013 - 01/2009
2	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 05/2013
2	LigandsIBA 01/2019 - 10/2005
2	UbiquitinIBA 01/2018 - 07/2004
2	Hormones (Hormone)IBA 01/2018 - 01/2015
2	Histones (Histone)IBA 01/2015 - 06/2008
2	Oxidants (Oxidizing Agents)IBA 01/2014 - 07/2010
2	Messenger RNA (mRNA)IBA 05/2013 - 10/2010
2	Therapeutic UsesIBA 02/2013 - 06/2011
2	Phosphotransferases (Kinase)IBA 07/2011 - 07/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2011 - 07/2004
2	Aligeron (AS 2)IBA 07/2010 - 07/2006
2	Epirubicin (Ellence)FDA LinkGeneric 02/2009 - 03/2007
1	Serine (L-Serine)FDA Link 10/2022
1	Phenylalanine (L-Phenylalanine)FDA Link 10/2022
1	Viral ProteinsIBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Cystine (L-Cystine)IBA 01/2022
1	OTX015IBA 11/2021
1	proto-oncogene protein Spi-1IBA 01/2019
1	AndrogensIBA 01/2019
1	Promyelocytic Leukemia ProteinIBA 10/2017
1	Listeria monocytogenes hlyA protein (listeriolysin O)IBA 10/2017
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2017
1	Trans-Activators (Trans-Acting Factor)IBA 01/2015
1	abexinostatIBA 01/2015
1	Estrogen Receptor alphaIBA 01/2015
1	Codon (Codons)IBA 09/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2013
1	8-((4-chlorophenyl)thio)cyclic-3',5'-AMPIBA 02/2013
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2013
1	Transcription Factors (Transcription Factor)IBA 07/2011
1	Tamoxifen FDA LinkGeneric 04/2011
1	Drug CombinationsIBA 12/2010
1	AnthracyclinesIBA 01/2010
1	Alkylating AgentsIBA 01/2010
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 06/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2008
1	Tumor Suppressor Protein p53IBA 01/2008
1	cellular retinoic acid binding protein IIBA 11/2007
1	CeramidesIBA 06/2007
1	ceramide glucosyltransferaseIBA 06/2007
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2007
1	CalcineurinIBA 06/2007

Therapy/Procedure

27	Therapeutics 03/2024 - 11/2004
16	Drug Therapy (Chemotherapy) 12/2015 - 06/2003
2	Lasers (Laser) 09/2013 - 02/2009
2	Homologous Transplantation 09/2013 - 02/2009
1	Castration 01/2019
1	Aftercare (After-Treatment) 08/2013
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2010
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2009